Amundi STOXX Europe 600 Healthcare UCITS ETF Acc

Amundi STOXX Europe 600 Healthcare UCITS ETF Acc is an exchange-traded fund (ETF) from Amundi, traded under the ticker CH5 (ISIN LU1834986900). One trade buys a whole basket of holdings, so your money is spread out instead of riding on a single company. At its core it is a focused, thematic fund: it concentrates on the health care part of the market, so it lives or dies by that one area rather than the economy as a whole. Underneath, it is about owning small slices of companies, so you share in their growth when they do well — and their falls when they don't. Rather than a manager picking stocks, it simply replicates the STOXX Europe 600 Health Care Net Return EUR index — the passive, low-cost approach, and its largest holdings include NOVARTIS AG-REG, ASTRAZENECA GBP and ROCHE HOLDING AG - GENUSSS CHF. By geography it is weighted towards ~39.8% Switzerland, ~23.8% United Kingdom and ~11.2% Denmark. Its heaviest sectors are ~98.9% Health Care and ~1.1% Materials. A focused fund like this is typically held as a smaller 'satellite' position around a broader core — a way to lean into one theme, not usually a portfolio's only holding. Its ongoing charge (TER) is 0.3% a year — about €30 a year on a €10,000 holding, taken automatically from the fund. Income such as dividends is automatically reinvested inside the fund (an accumulating share class), so returns compound without you doing anything. It tracks its index through a swap agreement rather than owning every holding (synthetic replication); it is domiciled in Luxembourg and UCITS-regulated, a European standard built to protect everyday investors and trades in EUR. Its price has swung about 17.1% over the past year, which describes how much its price tends to move rather than whether it is good. It launched in 2024. Like any investment, it can lose value as well as gain, and what it did before does not predict what it will do next. (Fund data sourced from Amundi.)